Bank of New York Mellon Corp lifted its position in NeoGenomics, Inc. (NASDAQ:NEO – Free Report) by 1.8% during the 4th ...

NeoGenomics, Inc.’s NEO share price has dipped by 10.05%, which has investors questioning if this is right time to buy.

NeoGenomics (NEO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more ...

TD Cowen analyst Daniel Brennan maintained a Buy rating on NeoGenomics (NEO – Research Report) today and set a price target of $19.00. The ...

In a report released today, Matt Hewitt from Craig-Hallum maintained a Buy rating on NeoGenomics (NEO – Research Report). The company’s shares ...

Neo Performance Materials is poised to benefit from the renewable and EV transitions, with its rare earth metals being ...

As I like to say, "A company's long-term stock price growth is based on its financial growth." Therefore, first let's take a look at pillars 3, 4 and 5. Over the past 5Y, Neo has been growing ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...